Small-Volume Blood Collection Tubes
DeviceSmall-volume vacuum (< 4 mL) ethylenediaminetetraacetic acid (EDTA), lithium-heparin, citrate, fluoride and serum blood collection tubes.
NCT Number: NCT03578419
STRATUS will evaluate the use of small-volume ("soft-draw") blood collection tubes for laboratory testing in reducing anemia and transfusion in intensive care unit patients without significant adverse consequences. This is a simple, cost-neutral intervention that could improve the quality of patient care and reduce the harms of frequent laboratory testing.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
University of Manitoba - Health Sciences Centre, Winnipeg, Manitoba, Canada
Blood sampling can cause significant unnecessary blood loss particularly in the intensive care unit (ICU). Blood loss contributes to anemia which is highly prevalent in the ICU and is associated with major adverse cardiovascular outcomes and death. Red blood cell (RBC) transfusions to correct anemia also have significant health risks.
Using a stepped wedge cluster randomized trial design, the specific aim of the STRATUS study is to evaluate whether the routine use of small-volume blood collection tubes reduces RBC transfusion compared to standard-volume blood collection tubes in adult ICU patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
ICUs will be eligible if they meet the following criteria:
Small-volume vacuum (< 4 mL) ethylenediaminetetraacetic acid (EDTA), lithium-heparin, citrate, fluoride and serum blood collection tubes.
Standard-volume (≥ 4 mL) ethylenediaminetetraacetic acid (EDTA), lithium-heparin, citrate, fluoride and serum blood collection tubes.
Time frame: through study completion, an average of 1.5 years
Average number of red blood cell (RBC) units transfused per patient during ICU admission among patients admitted to ICU for 48 hours or longer.
Time frame: through study completion, an average of 1.5 years
Change in hemoglobin concentration from ICU admission to ICU discharge adjusted for number of RBC transfusions received
Time frame: through study completion, an average of 1.5 years
Length of stay in the ICU and hospital
Time frame: through study completion, an average of 1.5 years
Mortality rates in the ICU and hospital
Population Health Research Institute
Other
Small-Volume Tubes to Reduce Anemia and Transfusion: A Pragmatic Stepped Wedge Cluster Randomized Trial
Acronym: STRATUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04744181
Anemia, Anemia, Hypochromic
Roma, Italy
View Trial DetailsNCT03680456
Anemia, Blood Loss Anemia
Linz, Austria
View Trial DetailsNCT03468738
Anemia, Blood Loss Anemia
Ankara, Turkey (Türkiye)
View Trial DetailsNCT03037515
Blood Loss Anemia, Blood Loss, Surgical
Detroit, Michigan, United States
View Trial Details